Evidence map›Paper›PMID 41978398›Full record

ArticleBeijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences2026

[Development and validation of a multicenter nomogram predicting the risk of liver metastasis after curative resection of colorectal cancer].

Nannan Wang, Dajin Yuan, Yubing Zhu, Lei Ding

Abstract readMulticenter StudyValidation StudyEnglish Abstract
PubMed Full text at PMC
In one paragraph

Article in Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Nannan WangDepartment of Gastrointestinal Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing 100038, China.
Dajin YuanDepartment of Gastrointestinal Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing 100038, China.
Yubing ZhuDepartment of Gastrointestinal Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing 100038, China.
Lei DingDepartment of Gastrointestinal Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing 100038, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo identify independent clinicopathological and molecular risk factors for metachronous liver metastasis and to construct a novel multicenter nomogram for predicting 1-, 3-, and 5-year liver metastasis-free survival (LMFS).

methodsIn this multicenter retrospective cohort study, we analyzed clinical data from 865 patients with stages Ⅰ-Ⅲ CRC who underwent curative resection between January 2020 and December 2024. The population was derived from two institutions: Beijing Shijitan Hospital (

resultsBaseline characteristics were balanced across cohorts (

conclusionWe established and externally validated a nomogram integrating clinicopathological features with

Indexed as

Colorectal NeoplasmsLiver NeoplasmsNomogramsAgedFemaleHumansMaleMiddle AgedMutationProto-Oncogene Proteins B-rafProto-Oncogene Proteins p21(ras)Retrospective StudiesRisk FactorsBRAF protein, humanKRAS protein, humanProto-Oncogene Proteins B-rafProto-Oncogene Proteins p21(ras)Colorectal cancerCurative resectionLiver metastasis-free survivalMetachronous liver metastasisNomogramPredictive model

Identifiers

PMID41978398
PMCPMC13077338

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.